These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21437370)

  • 21. Impact of fatty acid food reformulations on intake of Dutch young adults.
    Temme EH; Millenaar IL; Van Donkersgoed G; Westenbrink S
    Acta Cardiol; 2011 Dec; 66(6):721-8. PubMed ID: 22299382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trans fatty acids (TFA): analysis, occurrence, intake and clinical relevance.
    Steinhart H; Rickert R; Winkler K
    Eur J Med Res; 2003 Aug; 8(8):358-62. PubMed ID: 12915330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Foods with a high fat quality are essential for healthy diets.
    Zevenbergen H; de Bree A; Zeelenberg M; Laitinen K; van Duijn G; Flöter E
    Ann Nutr Metab; 2009; 54 Suppl 1():15-24. PubMed ID: 19641346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding the complexities of prevalence of trans fat and its control in food supply in Pakistan.
    Tarar OM; Ahmed KM; Nishtar NA; Achakzai ABK; Gulzar Y; Delles C; Al-Jawaldeh A
    J Clin Hypertens (Greenwich); 2020 Aug; 22(8):1338-1346. PubMed ID: 32687252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health effects of trans-fatty acids: experimental and observational evidence.
    Mozaffarian D; Aro A; Willett WC
    Eur J Clin Nutr; 2009 May; 63 Suppl 2():S5-21. PubMed ID: 19424218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Industrially produced trans fat: Usage, health implications, global and indian regulations.
    Chopra S; Arora C; Malhotra A; Khurana SC
    Indian J Public Health; 2021; 65(1):71-75. PubMed ID: 33753695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of trans fatty acid levels by FTIR in processed foods in Australia.
    McCarthy J; Barr D; Sinclair A
    Asia Pac J Clin Nutr; 2008; 17(3):391-6. PubMed ID: 18818158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trans-Fatty Acids and Cardiovascular Disease: Urgent Need for Legislation.
    Wilczek MM; Olszewski R; Krupienicz A
    Cardiology; 2017; 138(4):254-258. PubMed ID: 28946140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The scientific basis for trans fatty acid regulations-is it sufficient? A European perspective.
    Aro A
    Atheroscler Suppl; 2006 May; 7(2):67-8. PubMed ID: 16713395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trans fatty acids in food: A review on dietary intake, health impact, regulations and alternatives.
    Nagpal T; Sahu JK; Khare SK; Bashir K; Jan K
    J Food Sci; 2021 Dec; 86(12):5159-5174. PubMed ID: 34812504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trans-fatty acid content of food products in Spain in 2015.
    Pérez-Farinós N; Dal Re Saavedra MÁ; Villar Villalba C; Robledo de Dios T
    Gac Sanit; 2016; 30(5):379-82. PubMed ID: 27266514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of trans fats: the gap, the Polder, and McDonald's French fries.
    Katan MB
    Atheroscler Suppl; 2006 May; 7(2):63-6. PubMed ID: 16713390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Consumption of trans fats and estimated effects on coronary heart disease in Iran.
    Mozaffarian D; Abdollahi M; Campos H; Houshiarrad A; Willett WC
    Eur J Clin Nutr; 2007 Aug; 61(8):1004-10. PubMed ID: 17268422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatty acid composition of Swedish bakery products, with emphasis on trans-fatty acids.
    Trattner S; Becker W; Wretling S; Öhrvik V; Mattisson I
    Food Chem; 2015 May; 175():423-30. PubMed ID: 25577101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The scientific basis for TFA regulations-is it sufficient? Comments from the USA.
    Willett WC
    Atheroscler Suppl; 2006 May; 7(2):69-71. PubMed ID: 16716766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effectiveness of policies for reducing dietary trans fat: a systematic review of the evidence.
    Downs SM; Thow AM; Leeder SR
    Bull World Health Organ; 2013 Apr; 91(4):262-9H. PubMed ID: 23599549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The feasibility of multisectoral policy options aimed at reducing trans fats and encouraging its replacement with healthier oils in India.
    Downs SM; Thow AM; Ghosh-Jerath S; Leeder SR
    Health Policy Plan; 2015 May; 30(4):474-84. PubMed ID: 24829317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness analysis of eliminating industrial and all trans fats in England and Wales: modelling study.
    Pearson-Stuttard J; Hooton W; Critchley J; Capewell S; Collins M; Mason H; Guzman-Castillo M; O'Flaherty M
    J Public Health (Oxf); 2017 Sep; 39(3):574-582. PubMed ID: 27613767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Latin America and the Caribbean assessment.
    Viel B
    Draper Fund Rep; 1984 Jun; (13):23-5. PubMed ID: 12339635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trans fatty acid content in Malaysian supermarket foods: a field-to-laboratory approach in assessing food risk.
    Karupaiah T; Tan HK; Ong WW; Tan CH; Sundram K
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2014; 31(8):1375-84. PubMed ID: 24872121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.